Interestingly, GINS1 was identified as an anlotinib‐mediated downstream gene, and knockdown of GINS1 markedly inhibited the proliferation of synovial sarcoma cells (Tang et al., 2019). This evidence concerns the gene GINS1 and synovial sarcoma.